JP2025506783A5 - - Google Patents

Info

Publication number
JP2025506783A5
JP2025506783A5 JP2024549676A JP2024549676A JP2025506783A5 JP 2025506783 A5 JP2025506783 A5 JP 2025506783A5 JP 2024549676 A JP2024549676 A JP 2024549676A JP 2024549676 A JP2024549676 A JP 2024549676A JP 2025506783 A5 JP2025506783 A5 JP 2025506783A5
Authority
JP
Japan
Prior art keywords
gusacitinib
crystalline
hcl salt
salt according
ray powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506783A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/013668 external-priority patent/WO2023164024A1/en
Publication of JP2025506783A publication Critical patent/JP2025506783A/ja
Publication of JP2025506783A5 publication Critical patent/JP2025506783A5/ja
Pending legal-status Critical Current

Links

JP2024549676A 2022-02-23 2023-02-23 グサシチニブの固体形態 Pending JP2025506783A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
IN202211009506 2022-02-23
IN202211009506 2022-02-23
IN202211028117 2022-05-16
IN202211028117 2022-05-16
IN202211031922 2022-06-03
IN202211031922 2022-06-03
IN202211053997 2022-09-21
IN202211053997 2022-09-21
IN202311006675 2023-02-02
IN202311006675 2023-02-02
IN202311007408 2023-02-06
IN202311007408 2023-02-06
PCT/US2023/013668 WO2023164024A1 (en) 2022-02-23 2023-02-23 Solid state forms of gusacitinib

Publications (2)

Publication Number Publication Date
JP2025506783A JP2025506783A (ja) 2025-03-13
JP2025506783A5 true JP2025506783A5 (https=) 2025-11-04

Family

ID=85640884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549676A Pending JP2025506783A (ja) 2022-02-23 2023-02-23 グサシチニブの固体形態

Country Status (6)

Country Link
US (1) US20250171448A1 (https=)
EP (1) EP4482836A1 (https=)
JP (1) JP2025506783A (https=)
KR (1) KR20240151808A (https=)
CA (1) CA3244694A1 (https=)
WO (1) WO2023164024A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202510870A (zh) * 2023-07-27 2025-03-16 美商自由生物有限公司 Jak/syk抑制劑之組合物及固體形式
WO2025020171A1 (en) * 2023-07-27 2025-01-30 Libertas Bio, Inc. Crystalline forms of a jak/syk inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2748166T3 (pl) * 2011-08-23 2019-05-31 Asana Biosciences Llc Związki pirimido-pirydazynonowe oraz ich zastosowanie
WO2018187294A1 (en) * 2017-04-03 2018-10-11 Asana Biosciences, Llc Pyrimido-pyridazinone compound combinations, methods, kits and formulations thereof
EP3875078A1 (en) * 2020-03-06 2021-09-08 Dompe' Farmaceutici S.P.A. Compounds for the treatment of covid-19

Similar Documents

Publication Publication Date Title
JP2025506783A5 (https=)
JP2021504338A5 (https=)
JP2023532257A5 (https=)
JP2014524442A5 (https=)
JP2022543155A5 (https=)
JP2021501151A5 (https=)
JP2023036708A5 (https=)
JP2023002516A5 (https=)
JP2022502500A5 (https=)
JP2020111582A5 (https=)
CN112047927A (zh) 展现抗癌和抗增殖活性的n-酰基-n′-(吡啶-2-基)脲及类似物
JP2015522644A5 (https=)
JP6678711B2 (ja) マルトール第二鉄の結晶形態
JP2019516749A5 (https=)
JP2022517842A5 (https=)
JP2024543413A5 (https=)
JP2025504379A5 (https=)
JP2024095561A5 (https=)
CN114008028A (zh) 抑制癌细胞生长的嘧啶衍生物及其医药用途
JP7314319B2 (ja) Cdk9阻害剤の結晶多形体及びその製造方法と用途
AU2020211071A1 (en) New crystalline forms of a succinate salt of 7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide
JP2025508071A5 (https=)
RU2002135315A (ru) Производные хинолонкарбоновой кислоты
JP2018522945A5 (https=)
JP2022520410A5 (https=)